David N. Gill - 18 May 2021 Form 4 Insider Report for Strongbridge Biopharma plc

Role
Director
Signature
/s/ Judith Goldberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 19:10:07 UTC
Previous filing
17 May 2021
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBBP Ordinary Shares Award $0 +40,000 +72% $0.000000 95,821 18 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest in full on May 18, 2022, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.